Showing results (301-310 of 307) with videos related to
Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 307 results.
Human Molecular Genetics|May 5, 2012
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseasesGiovanni Coppola, Subashchandrabose Chinnathambi, Jason JiYong Lee, et al.Acta Neuropathologica|January 20, 2020
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevitySven J van der Lee, Olivia J Conway, Iris Jansen, et al.Acta Neuropathologica|February 11, 2019
Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLDCyril Pottier, Yingxue Ren, Ralph B Perkerson, et al.Acta Neuropathologica|May 28, 2019
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevitySven J van der Lee, Olivia J Conway, Iris Jansen, et al.Nature Communications|April 25, 2025
Deciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencingCyril Pottier, Fahri Küçükali, Matt Baker, et al.Nature Genetics|March 13, 2026
A repeat expansion in GOLGA8A is a major risk factor for atypical frontotemporal lobar degeneration with ubiquitin-positive inclusionsWouter De Coster, Marleen Van den Broeck, Matt Baker, et al.Medrxiv : the Preprint Server for Health Sciences|July 9, 2024
Deciphering Distinct Genetic Risk Factors for FTLD-TDP Pathological Subtypes via Whole-Genome SequencingCyril Pottier, Fahri Küçükali, Matt Baker, et al.Pageof 31